Histopathology · 2011 · 72 citations · 23 references
MedicineCancer BiologyOncologyMolecular OncologyNeoplasiaSignal TransductionAngiogenesisAngiogenesis In CancerCancer ProgressionMalignant NeoplasmsMammary TumorsTumor MarkersAngiogenesis In NeoplasmsTumor Angiogenesis SignalingTumor NeovascularizationVascular Endothelial Growth FactorVascular Endothelial Growth Factor Receptors
AIMS: This study aimed to identify the involvement of class 3 semaphorins (Sema3) and receptors, neuropilins (Np1 and Np2) and plexins (A1-A4) in breast cancer development and angiogenesis. METHODS AND RESULTS: We quantified and correlated Sema3A, Sema3B, Sema3F and their known receptors and coreceptors Plexin-A1, Plexin-A3, Np1 and Np2 in sections of normal human breast, benign and pre-malignant hyperplastic tissue, pre-invasive and invasive cancer, and compared these findings with our previously published data on vascular endothelial growth factor (VEGF) and microvessel density (MVD) in the same samples. Histological analysis revealed that Sema3B was expressed more strongly and widely than Sema3A and 3F in normal breast tissue and all three semaphorins decreased with the transition from in situ to invasive cancer (P < 0.014). Plexin-A3 decreased significantly with progression towards invasive cancer (P < 0.045), whereas Plexin-A1 expression was only significantly reduced once invasion had occurred (P = 0.012). Np1 and Np2 were expressed in both endothelial and epithelial/tumour cells. Np2 expression did not change, but Np1 expression significantly increased in the spectrum from hyperplasia to ductal carcinoma in situ (P < 0.035), but decreased with invasive cancer. CONCLUSION: These data suggest that a decrease in class 3 semaphorin and their plexin receptors have some relationship with disease progression in ductal breast carcinoma.
23
Yoshitaka Sekido, S. Bader, Farida Latif et al. · Proceedings of the National Academy of Sciences · 1996 · 236 citations
Noga Guttmann‐Raviv, Niva Shraga‐Heled, Asya Varshavsky et al. · Journal of Biological Chemistry · 2007 · 229 citations · Full text
Semaphorin-3F Is an Inhibitor of Tumor Angiogenesis
Ofra Kessler, Niva Shraga‐Heled, Tali Lange et al. · Cancer Research · 2004 · 225 citations
Yoshio Tomizawa, Yoshitaka Sekido, Masashi Kondo et al. · Proceedings of the National Academy of Sciences · 2001 · 209 citations · Full text